Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study
Світлана Зубченко, Iryna Kril, Олена Надіжко, et al.
Rheumatology International (2022) Vol. 42, Iss. 9, pp. 1523-1530
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2794
The immunology of long COVID
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 265
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 82
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 51
Reactivation of herpesviruses during COVID‐19: A systematic review and meta‐analysis
Arman Shafiee, Mohammad Mobin Teymouri Athar, Mohammad Javad Amini, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 3
Closed Access | Times Cited: 43
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 27
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 21
Cognitive dysfunction in post‐COVID‐19 condition: Mechanisms, management, and rehabilitation
Marika C. Möller, Kristian Borg, Christer Janson, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 5, pp. 563-581
Open Access | Times Cited: 39
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 33
Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients
Keishanne Danielle E. Bernal, Christopher B. Whitehurst
Virus Research (2023) Vol. 334, pp. 199157-199157
Open Access | Times Cited: 31
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
Farigol Hakem Zadeh, Daniel R. Wilson, Devendra K. Agrawal
Archives of Microbiology & Immunology (2023) Vol. 07, Iss. 02
Open Access | Times Cited: 29
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis
Martin Achleitner, Charlotte Steenblock, Juliane Dänhardt, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2872-2877
Open Access | Times Cited: 28
Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field
Ana Banko, Danijela Miljanovic, Andja Ćirković
International Journal of Infectious Diseases (2023) Vol. 130, pp. 108-125
Open Access | Times Cited: 24
Long COVID in autoimmune rheumatic diseases
Yuliya Fedorchenko, Olena Zimba
Rheumatology International (2023) Vol. 43, Iss. 7, pp. 1197-1207
Open Access | Times Cited: 24
Viral reactivations and co-infections in COVID-19 patients: a systematic review
Jenny Yeon Hee Kim, Martín Ragusa, Fernando Tortosa, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort
Kristine M. Erlandson, Linda N. Geng, Caitlin Selvaggi, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 9, pp. 1209-1221
Closed Access | Times Cited: 15
Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome
Aristo Vojdani, Abbas F. Almulla, Bo Zhou, et al.
Acta Neuropsychiatrica (2024) Vol. 36, Iss. 3, pp. 172-184
Open Access | Times Cited: 11
Epstein–Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients
Bailey Brooks, Christina Tancredi, Yufeng Song, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1872-1872
Open Access | Times Cited: 30
The global challenges of the long COVID-19 in adults and children
Alfonso J. Rodríguez‐Morales, María Camila Lopez-Echeverri, Maria Fernanda Perez-Raga, et al.
Travel Medicine and Infectious Disease (2023) Vol. 54, pp. 102606-102606
Open Access | Times Cited: 20
Long COVID: what is known and what gaps need to be addressed
Benjamin A. Krishna, Mark R. Wills, Nyaradzai Sithole
British Medical Bulletin (2023) Vol. 147, Iss. 1, pp. 6-19
Open Access | Times Cited: 18
Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review
Ying Zhu, Lokesh Sharma, De Chang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Long COVID’s Impact on Patients, Workers, & Society: A review
Kevin T. Kavanagh, Lindsay E. Cormier, Christine Pontus, et al.
Medicine (2024) Vol. 103, Iss. 12, pp. e37502-e37502
Open Access | Times Cited: 8
Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6389-6389
Open Access | Times Cited: 8
Herpesviruses and SARS-CoV-2: Viral Association with Oral Inflammatory Diseases
Jonathan M. Banks, Kristelle J. Capistrano, Daniela Atili Brandini, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 58-58
Open Access | Times Cited: 7
Current landscape of long COVID clinical trials
Manojit Bhattacharya, Srijan Chatterjee, Sanskriti Saxena, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111930-111930
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top